Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-25-022874
Filing Date
2025-06-18
Accepted
2025-06-17 21:50:49
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFA14A ef20050743_defa14a.htm DEFA14A 49178
  Complete submission text file 0001140361-25-022874.txt   50251
Mailing Address WALLSTRASSE 16 BERLIN 2M 10179
Business Address WALLSTRASSE 16 BERLIN 2M 10179 49 89 2153 9035
ATAI Life Sciences N.V. (Filer) CIK: 0001840904 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40493 | Film No.: 251055047
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)